Expression and purification of Mycobacterium tuberculosis trehalose-6-phosphate phosphatase OtsB2, and crystalline three-dimensional structure of complex of Mycobacterium tuberculosis trehalose-6-phosphate phosphatase OtsB2 and phosphoric acid
A technology of Mycobacterium tuberculosis and phosphatase, applied in hydrolase, microorganism-based methods, biochemical equipment and methods, etc., can solve problems such as little research on drug targets
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Construction of mycobacterium tuberculosis trehalose-6-phosphate phosphatase OtsB 2 Soluble expression vectors, methods for obtaining large amounts of expressed strains
[0040] The inventors initially tried to convert OtsB 2 Full-length protein expression, trying to construct different expression vectors pGEX, pET, etc., and different expression strains, such as BL21(DE3), BL21(DE3)pLyss, Transetta(DE3), etc., to obtain a large amount of expression of soluble OtB 2 Protein recombinant vector pET-28a, and strain BL21 (DE3).
[0041] OtsB of Mycobacterium tuberculosis H37Rv 2 expression purification method
[0042] The above-mentioned construct containing OtsB 2 The recombinant expression vector of the gene was transformed into Escherichia coli BL21 (DE3) to express the target protein, and the Escherichia coli prokaryotic system was used to express the fusion protein with 6 His tags connected to the N-terminus (amino-terminus), and the front of the tag contained Th...
Embodiment 2
[0046] OtsB of Mycobacterium tuberculosis H37Rv 2 crystallization of
[0047] The OtsB2 protein of Mycobacterium tuberculosis H37Rv expressed and purified by the above method was concentrated to a concentration of about 10-20mg / mL, and DTT was added to a final concentration of 10mM, using a crystallization reagent (Crystal Screen Kit I / II, Index, Salt, PEG / ion, Additive Screen and other kits), and crystallized by gas-phase hanging drop method at 4, 16 and 25 degrees Celsius respectively, and carried out preliminary screening of crystal growth conditions. After preliminary screening, the inventors obtained initial crystals under different conditions of crystallization reagents. By adjusting the reagent concentration in the pool solution, the conditions are: 11.5% PEG20000, 0.12MMes (pH=6.5), needle-like crystals were obtained, and a set of X-ray parent diffraction data with a resolution of 3.5 angstroms was collected.
Embodiment 3
[0049] OtsB of Mycobacterium tuberculosis H37Rv 2 The method of selenoprotein carrier construction
[0050] The inventors initially tried to mutate the leucine at the 29th, 133rd, 172nd, 285th and 379th positions of OtsB2 into methionine by point mutation technology, and then respectively mutated The recombinant vector was expressed and purified, and the results of SDS-PAGE showed that only the recombinant vector containing two mutations at 29 and 133 could express a large amount of protein.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com